Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 1;183(4):386-388.
doi: 10.1001/jamainternmed.2022.6795.

A Polygenic Risk Score for Prostate Cancer Risk Prediction

Kerry R Schaffer  1   2 , Mingjian Shi  3 , John P Shelley  3 , Jeffrey J Tosoian  2   4 , Linda Kachuri  5 , John S Witte  5   6 , Jonathan D Mosley  1   3
Affiliations

A Polygenic Risk Score for Prostate Cancer Risk Prediction

Kerry R Schaffer et al. JAMA Intern Med. .
No abstract available

Plain language summary

This retrospective cohort study compares 2 risk calculator systems that compute the probabilities of finding high-grade or any cancer on biopsy results in men undergoing a first prostate biopsy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Tosoian reported grants from LynxDx Equity outside the submitted work. Dr Mosley reported grants from the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) during the conduct of the study. No other disclosures were reported.

Comment in

References

    1. Darst BF, Sheng X, Eeles RA, Kote-Jarai Z, Conti DV, Haiman CA. Combined effect of a polygenic risk score and rare genetic variants on prostate cancer risk. Eur Urol. 2021;80(2):134-138. doi: 10.1016/j.eururo.2021.04.013 - DOI - PMC - PubMed
    1. Klein RJ, Vertosick E, Sjoberg D, et al. Prostate cancer polygenic risk score and prediction of lethal prostate cancer. NPJ Precision Oncology. 2022;6(1):25. - PMC - PubMed
    1. Bakshi A, Riaz M, Orchard SG, et al. A polygenic risk score predicts incident prostate cancer risk in older men but does not select for clinically significant disease. Cancers (Basel). 2021;13(22):5815. doi: 10.3390/cancers13225815 - DOI - PMC - PubMed
    1. Conti DV, Darst BF, Moss LC, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nat Genet. 2021;53(1):65-75. doi: 10.1038/s41588-020-00748-0 - DOI - PMC - PubMed
    1. Ankerst DP, Straubinger J, Selig K, et al. A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts. Eur Urol. 2018;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003 - DOI - PMC - PubMed

Publication types